Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Sweden
Finland
Denmark
Norway
Latest
Trending
Followed

Haypp Group, Audiocast, Q2'25

By Inderes8/7/2025, 7:00 AM
Haypp Group

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Unknown 1
00:00 - 00:00

Ahead.

Gavin O'Dowd
00:03 - 06:36

Good morning, everyone, and welcome to our Q2 2025 conference call. Our CFO, Peter Delly, and I, Gavin O'Dowd, will take you through our results starting at slide four. I would like to focus on three key aspects of our operational highlights, beginning first with our nicotine pouch Q2 volume, which showed a year-on-year growth of 23% on a like-for-like basis. We would like to highlight that this doesn't reflect two key impacts on comparability, which reduced our growth rates: one, the Easter effect, which moved from Q1 in 2024 to Q2 in 2025, which we highlighted in our Q1 presentation. We estimate that this impacted growth by approximately three percentage points. And two, in Q2 2024, it was an exceptional quarter driven by shortages in the US. Much of the incremental traffic we received due to these shortages resulted in sales of non-US Zyn brands, which grew over 50% quarter on quarter in Q2 24. Please refer to our Q2 24 presentation for more context. Adjusting for these factors, nicotine pouch growth rates are similar in Q2 to Q1 2025. Secondly, revenue continued to grow at approximately 20% on a like-for-like basis, adjusting for Easter. In line with the last 12 months performance. And lastly, I would like to draw your attention to the material increase in our gross margin. Our business philosophy is built around sharing our economies of scale with our consumers in the form of superior convenience and best value. And despite aggressively moving forward on both of these areas, Haypp was still able to increase its gross margin by nearly five percentage points to 19%, reflecting the power of our operating model. Moving to slide five. I'd like to touch on how the US market is changing and how we are investing. Starting with the market on the left-hand side, the overall market continues to show robust growth, driven both by customers moving into the category and by increased consumption rates for those who have been in the category for a number of years. The US Nicotine pouch category is now larger than the US legal category. In parallel, fragmentation within the category continues to accelerate with further introductions of FDA-approved products. As an anecdote, we launched more Nicotine pouch SKUs in the US in Q2 2025 than in all of 2024. Regulation remains stable, with early signs of an increasing emphasis on ensuring that existing rules are complied with rather than introducing new legislation. While this is more evident in the vape category, it bodes well for nicotine pouches as well. In conclusion, we believe the overall conditions for compliant online retail are extremely bright, and we will continue to allocate resources accordingly. Moving to the right-hand side of the slide, which focuses more on our US investment priorities, which we touched upon in our Capital Markets Day in April. Since then, we have reinforced the team capabilities, with our CTO recently relocating to our US office. In addition, we have recruited a Head of Customer Acquisition, and in keeping with our commitment to compliance, we have onboarded both Heads of Legal and Regulatory Affairs. We consider these additions to our team to be an excellent bedrock to build a sustainable business from. We will focus much of our effort in recent months towards further improving our retention rates, which is key to maximizing the returns we will achieve from new customers in the future. Initiatives such as the same-day delivery in Houston, which has now been expanded to a broader area, and the new loyalty program, are key drivers to this improvement. While we continue to further sharpen our retention rates, we will also trial a range of tools to accelerate our customer acquisition rates and assess their success before allocating material resources. And finally, as we said in our Q1 release, we see US Zyn supply and demand aligning within the US market, and we continue to expect a return to selling Zyn at some stage in the second half of 2025. Moving to slide six, which covers legal and regulatory updates. We remain engaged in two legal cases in Stockholm. The appeal process is ongoing, in line with expectations. We expect this will take between 1 and 6 months. And as previously stated, we don't expect any material impact from the outcome of this case. In San Francisco, settlement discussions are ongoing. The EU released an initial draft of a tax proposal on nicotine products, including nicotine pouches. As with previous EU tobacco tax initiatives, we expect the final outcome to be radically different from the initial proposal, especially given the number of member states that have openly opposed this draft. However, we do welcome that nicotine pouches are clearly recognized as a category in the draft, which is a strong step towards recognizing the category in other areas of regulation. In the UK, a nationwide ban on disposable nicotine vaping devices came into effect on June 1st, 2025. Vape manufacturers are changing to similarly branded rechargeable plug systems to limit consumer confusion. We believe the shift benefits online retailers over the long term through high prices and full compliance with new regulation. However, the transition by offline retailers from disposables continues, creating a temporary distortion within the market. With that, I will now hand over to Peter for an update on our financial performance. Thank you. Good morning everyone. We have concluded a successful quarter for underlying sales.

Peter Delly
06:36 - 12:41

Successful quarter for underlying sales. Development remained robust and gross margin increased further, allowing us to initiate the necessary investments primarily towards the US market to lay the foundation for the next chapter. Despite the increased level of investment, our adjusted EBITDA grew by 15 basis points versus last year to 4.2%. On slide seven, let me begin with our sales development. As has been highlighted, to properly understand the underlying performance similar to Q1, we must consider not only the impact of the discontinuation of Zyn tobacco and the closure of some states in the US, but also the phasing of Easter. While Q2 is lower than reality due to the Easter timing. To mitigate this distortion, we should look at extended periods from January to April and March to June. Growth rates for this period are very similar, around 20% year over year. There is no change in the product composition of growth drivers. The reported 17% growth is mainly driven by nicotine pouches, while Snus decline mainly in Sweden impacts our performance negatively by 3%. However, this is fully offset by the emerging segment contribution of 3% to the overall growth. On slide eight. Going into more detail about the like-for-like sales development, you can find the key drivers for the year-over-year sales growth on a like-for-like basis. All business units contributed to the growth. The main driver remained in the US; foreign exchange movements, particularly the depreciation of the Norwegian krone and US dollar against the Swedish krona, have negatively affected reported sales. As discussed earlier, it impacted both business units relative to the growth rates. It had a bigger impact on the core markets. Excluding the impact of Easter, the core markets grew by 9% while the growth segment grew by 51%. Moving to slide nine and progressing a few lines down in the P&L, you can find the long-term quarterly development of Haypp Group's gross margin, both in absolute terms and as a percentage of net sales compared to last year. The increases are consistent with those in Q1. Yes, but we managed to increase our gross margin, driven by consistent volume and top line growth and by the increasing contribution of our media and insight business. When looking at the increase versus Q2 2024, it is important to highlight that the discontinued part of our US business was not a major contributor to the gross margin pool. So the reduction in sales without a significant negative impact on the gross margin explains around two percentage points of the year-over-year difference versus last year. In Q1, we achieved a major step up in gross margin rates. We managed to further improve these rates thanks to the increased contribution of the media business. I would like to reaffirm the foundational principles of our business model. We allocate the value created by our company across consumers, business partners, and shareholders. Our ongoing priority is to enhance the value we provide to consumers, which in turn requires us to strengthen the value we generate for our business partners by continuously improving our media and insights offering. We are able to deliver greater value and convenience to our consumers while also driving healthier profit margins. Moving to slide ten. I would like to provide an overview of our overhead base, which increased by 270 million SEK in the quarter. This increase is mainly driven by the US and other growth markets, attributed to enhanced local team capabilities, category awareness, and PR efforts. On slide 11, you can see the key figures around our profitability. On this slide, we highlight key metrics and trends in overall profitability. Adjusted EBIT for the second quarter grew by 11%, reaching 38.3 million. The adjusted EBIT margin increased by 4.2%. The increase is driven by a better gross margin, partly offset by increased investments. Investments into the US organization and in Europe boosted brand awareness. Though one of the first in Sweden impacted, the Q2 margin level is a step back versus the record high Q1. It is still 50 basis points better than Q2 2024. The increase is partly driven by the US warehouse automation, which was installed in the middle of December last year. We maintain the investment into the emerging segment. This quarter, the investment amounted to 11.4 million SEK and reduced the overall adjusted EBIT of the group by 1.2 percentage points. Adjusted EBIT for the core and growth business units was 5.4%, above the 5% mark we targeted earlier. Moving to page 12 and our core markets. I mentioned that this segment delivered an overall 6% constant currency net sales growth. Q2 was heavily impacted as the growth during the March to June period was 9% behind the anticipated sales growth. The completely different dynamics remained in the MP segment, which accounted for 55% of the volume for core markets, up by six percentage points since Q2 2020. To maintain growth and consistently gain share, the Snus segment volume remained in decline, driven by a reduction in underlying consumer demand. These two opposite dynamics mean that the share of the fast-growing segment will improve the overall growth rate of the core markets.

Unknown 2
12:44 - 12:53

Pause for a moment and reset the sound. We're going to pause the conference call for a moment to try to adjust the sound. Bear with us, please.

Operator
13:02 - 13:06

We are experiencing some technical problems. We will come back shortly.

Gavin O'Dowd
13:19 - 13:20

After.

Unknown 1
13:23 - 13:24

Disconnected.

Peter Delly
13:24 - 13:33

Can you hear us? Patrick, can you hear us? Excellent. We apologize for the technical difficulties.

Unknown 3
13:36 - 13:37

You can continue. We maintain the investment into the emerging segment.

Peter Delly
13:38 - 16:06

Page 12. And our core markets. Um. Two different, uh, front segment dynamics. What we experienced, as I mentioned to you, was the nicotine pouch segment growing while the Snus is declining, and these two dynamics mean that the share increase of the fast-growing segment will improve the overall growth rates of the core markets. Adjusted EBITDA remained strong for this segment. The 10.2% Q2 results are 1.6 percentage points above last year. The driver behind the increase is clearly the media revenue. Moving to the next slide. Slide 13. Annual growth markets net sales, excluding currency impact on a like-for-like basis, are up by 49%. Looking at an extended period from March to June to mitigate the impact, this growth is 51% while all markets increase their sales. We are very pleased with the high double-digit growth rates of the US and nicotine pouch volume development in the UK. Adjusted EBITDA. In absolute terms, amounted to 3.1 million and adjusted EBITDA rate is 1.5%, while the profitability is stable versus the same period last year. It is a reduction versus Q1. Gross margin remained stable for the segment. However, the increase is mainly driven by the US, which negatively impacted the business unit's profitability. On slide 14, our emerging segments. The sequential sales growth continued, and we are particularly pleased with the Swedish and German market performance. Q2 in the UK was challenging due to the turbulent market conditions caused by the disposable vape market. Investment levels remain stable in this category versus the previous quarter. Moving to slide 15. I would like to highlight 3 or 4 selected KPIs. The full list of KPIs is available in the appendix of this presentation. You can find it on our website. Here, I would like to highlight three important metrics connected to the health of our balance sheet. Inventory level, working capital, and our leverage. There is no major change versus the end of Q1. Overall, our balance sheet remained healthy, with the net debt to adjusted EBITDA ratio remaining at 0.4 times. There is no major change in our working capital. With this, I would like to hand back to Gavin.

Gavin O'Dowd
16:09 - 18:19

Thank you, Peter. Moving to our outlook slide. Slide 17. In our view, the long-term future for risk-reduced nicotine products looks promising. The online channel and Haypp Group, with its many strengths, remains very encouraging. Haypp Group's operating model continues to generate increasing value for consumers and suppliers while also providing margin expansion. The expected increase in regulatory requirements is beginning to manifest, which further differentiates us given our sustained focus and investment in long-term compliance, as highlighted in our Capital Markets Day in April. The conditions in the US market provide a significant opportunity for long-term value creation. As such, we expect to invest heavily over the medium term, which is expected to impact our short to medium-term earnings. And finally, on slide 18, we would like to touch upon our medium-term guidance from the Capital Markets Day in April, which runs until 2028. We envision revenue growth rates of 18 to 25% over the period, with the US market being a material contributor. This reflects the lower expected reported growth rates for 2025, due to the comparatively narrower consumer base in the US. We also guide towards 5.5% EBIT at the end of the period, plus or minus 150 basis points. While we have been materially increasing our EBIT over the last two years, we intend to reinvest part of this into the US to accelerate our market share growth over this period. We intend to reinvest part of this into the US to accelerate our market share growth over this period. I would kindly direct your attention to our recent Capital Markets Day material, which is available on our group site. This provides more detail behind these targets. And lastly, the company does not intend to issue a dividend over this period, instead reinvesting surplus cash flows into the company's future expansion. Before I open up for questions, I would like to take the opportunity to thank my colleagues for their dedication and hard work in delivering these strong results. With that, I will hand over to the operator for questions. The expected increase in regulatory requirements is beginning to manifest, which further differentiates us given our sustained focus and investment in long-term compliance, as highlighted in our Capital Markets Day in April.

Operator
18:23 - 18:41

I wish to ask a question. Please dial the pound key on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial the pound key on your telephone keypad. The next question comes from Johan Fred from SEB. Please go ahead.

Johan Fred
18:43 - 19:12

Hi. Good morning, everyone. Thank you for taking my questions. Hey, the first question is on the gross margin development. A very solid development, considering the lower sales year on year. Uh, you state that this is driven by media, insights, and scale, which, in terms of media and insights, I remember are typically annual contracts. And, thus should we expect gross margins to maintain at similar levels going into H2?

Peter Delly
19:16 - 19:40

Good morning. Um, thanks for the question. Uh, yes. You are right that we are running with annual media contracts, but it doesn't mean that the monthly or quarterly phasing of the revenue is always the same. It’s similar, but not exactly the same. I think looking ahead for Q3 and Q4, you can expect a similar level of margins as we delivered in Q1 and Q2. Not the exact same, but within these ranges.

Johan Fred
19:42 - 20:05

Yeah. Got it. Very clear. And the second one, if I may. I noticed that you've added around 40 new employees during the quarter. Um, while you mentioned in the report that some key hires are related to the US. Could you also elaborate on where the majority of these new roles are located, and what functions or strategic areas are they focused on?

Gavin O'Dowd
20:06 - 20:30

Good morning Johan, and how are you doing? Firstly, um, yes, we have been adding materially to the US team, although it's more at a senior level that we're adding into it. I think it's probably also worth reflecting that there might have been a small mistake in the Q1 report, I would expect the numbers to be coming in more in the high teens.

Johan Fred
20:33 - 20:56

You are right that we are running with annual media contracts, but it doesn't mean that the monthly or quarterly phasing of the revenue is always the same. Got it. Um, and so in the high teens, is this roughly relating to the role? My question is really, is this you staffing up ahead of the supply or the return of supply in the US, i.e., Uh, factory workers or, or those kinds of positions?

Gavin O'Dowd
20:56 - 21:25

No, our warehouse infrastructure, and this is equally valid for the US as well, is highly automated. So we're able to manage substantial increases in volume without materially having to increase our warehouse employees across any of our warehouses at this point in time. What you're seeing here is more of a focus on both, predominantly the US, as regards setting up some of the initiatives which we're driving forward at this point in time, and also some other key growth markets, particularly the UK.

Johan Fred
21:28 - 21:48

Got it. Very clear. And the final one, if I may, um, you stated that you expect the supply to return at some stage during H2. Um, do you expect this to happen more towards, uh, Q3 or Q4? Any sort of guess there?

Gavin O'Dowd
21:49 - 22:04

This is always a slightly complex point to discuss since there are ongoing discussions with various suppliers at any point in time. But what we can say on this one is that when we have more information, we will be sure to inform you at that point in time.

Johan Fred
22:07 - 22:09

Got it. Uh, those were all my questions for now. Thank you so much.

Gavin O'Dowd
22:10 - 22:10

Thank you. John.

Operator
22:15 - 22:18

The next question comes from Nicholas from Eckman. Please go ahead.

Nicholas
22:20 - 22:58

Thank you. Yes. Uh, following up on some of John's questions here, um, as you said, the gross margin here is very strong. But we also observed a significant increase in operational expenses, which eroded much of the gross margin expansion here in Q2. I'm just wondering, given that you are investing now and recruiting, and I assume that some of these recruiting costs weren't fully realized in Q2, is it likely to assume that OpEx will increase further in H2, and that the margin expansion we saw here might be even lower? The EBIT margin expansion might be even lower, or we might even see contracting margins in H2.

Peter Delly
23:00 - 23:40

Good morning. Thanks for the question. Uh, what we are doing is basically executing the strategy we laid down in the CMD. We identified the US as a key market for growth opportunities, but we also recognize that the team we had in 2023 or even in 2024 might not be sufficient to capture that opportunity. So we started to build up that team already in Q2, and we are going to continue this work throughout Q3. So yes, I would not be surprised if we would see a further increase in our overheads. This can then result in a margin reduction compared to Q2.

Gavin O'Dowd
23:43 - 23:55

And that was the point. And that was the point that I was trying to touch on in. One of my points here is that we do expect a slight Ebit reduction for the remainder of the year from here.

Nicholas
23:59 - 24:28

Got it. Very clear. Thanks for settling that. Um, I'm also curious, when looking at customers here, there's about a 9% drop in the number of customers. And I assume that most of this is related to Zyn in the US and some of these calendar effects, but also that even in core markets you see a slight reduction in the number of customers. And can you elaborate a little bit on the drivers behind this. And if you think this could reverse shortly.

Gavin O'Dowd
24:28 - 25:20

Yeah. So, I think there are two factors contributing to that. One, I think the biggest factor by far is within the US. I think it's worth bearing in mind that in Q2 24, there was a material spike in our customer numbers relative to Q1 24. Some of those customers went on to purchase US Zyn in substantial amounts. Some of those customers went through to buying other SKUs as well. But there was a material step-up in our customer numbers in the US in Q2 of 2024. So that's by far the biggest driving force behind that. The second force is the calendar effect concerning when Easter fell, but it has a much smaller impact on us than the first one.

Nicholas
25:22 - 25:58

Okay. Very clear. And finally, you just mentioned the EU Commission and the potentially significant tax increase that they propose for nicotine pouches. Um, can you provide some more details here? What kind of magnitude of tax are we talking about? And obviously, recognizing that the final decision could be significantly different from what has been proposed. But what is the proposition and what is the normal timeline for when this goes from proposition to being actually implemented?

Gavin O'Dowd
25:59 - 26:50

Yes, Nicholas, and I can only caveat very heavily that, and I think I'm not alone when it comes to other announcements that come out around this, nobody pays a huge amount of heed to what the initial draft is. Because if you look back at every previous process which went through like this, the final outcome is significantly different as it runs through. And the proposal at this point in time would introduce a tax of roughly €2 per nicotine pouch can across the border for your average nicotine pouch. It's driven by weight, and as the products have been getting somewhat lighter over the years, that might be reducing a little bit from there. However, the time frame for that coming in would be somewhere between 2028 and 2030. However, I don't envisage that; I would consider it to be highly unlikely that it will be a quantum near that level which comes in.

Nicholas
26:53 - 27:12

Very, very clear. And do you think there's any likelihood, given the Swedish exception or the exemption from the Snus ban, any likelihood that the Swedish market could treat this differently, and certainly the Norwegian market could treat it differently, given that it's not part of the EU?

Gavin O'Dowd
27:13 - 27:54

Yeah, well, it's even more complex. So, Norway, of course, is a standalone case in itself, and so would Switzerland be. But it's even more complex with markets like Norway and also the UK, which are, of course, three very big markets for us at this point in time. But even if you look at those which are sitting within the EU at this point in time, there have been a significant number of countries that have come out and stood against this very firmly at this point in time. So I think this is more a case of us taking this opportunity to explain to people what has been published as the initial draft, rather than taking this particularly seriously as a potential outcome. So I would consider this to be a relatively low probability of manifesting in its current form.

Nicholas
27:56 - 27:59

Very clear, very clear. Thank you so much for taking my questions.

Gavin O'Dowd
27:59 - 27:59

Thank you.

Peter Delly
28:00 - 28:00

Thank you.

Operator
28:05 - 28:12

There are no more questions at this time, so I hand the conference back to the speakers for any written questions and closing comments.

Unknown 4
28:20 - 28:20

All right.

Gavin O'Dowd
28:22 - 28:29

Perfect. Thank you very much for your time, everybody. And I look forward to catching up on our Q3 call in three months.

Continue to the webcast
Pierce Group, Audiocast, Q3'26
Language: English11/13/2026, 8:00 AM
Göran Dahlin Good morning, everyone, and welcome to Pierce Group's presentation of our Q3 2026 interim results. Next slide, please. I am Göran Dahlin, CEO of Pierce Group, and I am with Fredrik Kjellg…
Surgical Science Sweden, Audiocast, Q3'26
Language: English11/12/2026, 10:00 AM
Tom Englund Hi everyone, and welcome to this earnings call for Surgical Science for the third quarter of 2026. My name is Tom Englund. I am the CEO. And with me today is our CFO, Anna Ahlberg. I wil…
ExpreS2ion Biotech – Presentation of Q3 2026 Interim Report
Language: English11/12/2026, 9:00 AM
ExpreS2ion is expected to release its Q3 2026 interim report on 12 November 2026. Later the same day at 10.00, ExpreS2ion’s CEO Bent U. Frandsen and CFO Keith Alexander will present the results and answer questions in a live online event.
Meko Services AB, Q3'26
Language: English11/12/2026, 8:00 AM
Pat Thank you. Good morning, and welcome to MEKO's presentation of the third quarter of 2026. I am here with our CFO, Christy Johansson, and I will begin with an overview of the quarter and some of th…
WeSports Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Unknown 1 It. Ted Sporre Welcome to our Q3 release presentation. As you know, we have already shared preliminary figures for sales and EBITDA for this quarter, but today we complete the picture. We wi…
Nordrest Holding, Audiocast, Q3'26
Language: Swedish11/12/2026, 8:00 AM
Thomas Dahlstedt Hej och välkomna! Vi ska idag presentera Nordrests senaste kvartal och tillika resultatet för perioden. Jag som pratar nu heter Thomas Dahlstedt och är grundare och tillika VD för bol…
Karnov Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Pontus Bodelsson Welcome, everyone, to Karnov Group's earnings conference, where we will present the outcome of the third quarter of 2026. Please go to slide two. I am Pontus Bodelsson, President and…
Fasadgruppen Group, Audiocast, Q3'26
Language: English11/12/2026, 7:15 AM
Magnus Blomberg Perfect. Good morning and welcome to the Fasadgruppen presentation of our results for the third quarter 2026. My name is Magnus Blomberg. You have met me before. I am the CFO of Fasadg…
Munters AB, CMD
Language: English11/11/2026, 1:00 PM
Lena Dauvergne Good. Good afternoon everyone, and a warm welcome to Stockholm, to ESSEX and to Montage Capital Markets Day 2026. Montage Capital Markets Day 2026. It is really good to see so many of y…
Cinclus Pharma, Audiocast, Q3'26
Language: English11/11/2026, 1:00 PM
Christer Ahlberg Thank you. Hello and welcome to the Cinclus Pharma third quarter 2026 earnings call. I am Christer Ahlberg, CEO of Cinclus Pharma, and with me today is our CFO, Magnus Christensen. We…
Proact IT, CMD
Language: English11/11/2026, 12:30 PM
Unknown 1 The world of data is constantly changing. Breaches are rising, and attacks are getting more advanced. Regulation drives the need for data sovereignty. Data has to be available. Critical busi…
Ferronordic AB, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Henrik Good morning, everyone, and welcome to our presentation of the third quarter of 2026. During the quarter, we saw higher earnings, and growing aftermarket revenue was up 15% to 1.2 billion Swedi…
BICO, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Anders Fogelberg Good morning, everyone, and welcome to BICO's earnings call for the third quarter of 2026. I am Anders Fogelberg, President and CEO of BICO. And joining me today is our Group CFO, Ewa…
Catena Media, Audiocast, Q3'26
Language: English11/10/2026, 5:00 PM
Manuel Stan Good afternoon. Good evening, everyone. Welcome to the Catena Media Q3 Interim Report. I am Manuel Stan and today I'm joined by our Chief Financial Officer, Michael Gerrow. Today we will b…
Ellos Group, Q3'26
Language: English11/10/2026, 8:00 AM
Hans Ohlsson Live. Good morning, everyone, and welcome to the second presentation for Ellos Group as a listed company. We have 45 minutes today for the presentation. And there is a hard stop. After th…
Scandic Hotels Group, Audiocast, Q3'26
Language: English11/10/2026, 8:00 AM
Jens Mathisen Thank you so much, and good morning, everyone, and thank you for joining us for the Q3 presentation. I am Jens Mathisen, CEO of Scandic. And joining me is our CFO, Pierre Carstensen. We…
Svevik Industri, Q3'26
Language: Swedish11/6/2026, 9:00 AM
Johan Hårdén Tack så mycket! Hello and welcome to this hearing regarding the Q3 2026 interim report. We have an agenda where we intend to introduce ourselves to all the new shareholders as well. Kort…
Attendo, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Martin Tivéus Good morning, everyone, and thank you for joining us. Today, we will present our results for the third quarter of 2026. I am pleased to announce that this is the strongest quarter for At…
Cavotec, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
David Pagels Good morning and welcome to Cavotec's Q3 2026 presentation. I am David Pagels, the CEO of Cavotec. And together with me today, I have our new CFO, Christoffer Robertsson. I would like to…
Fractal Gaming Group, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Jonas Good morning, everyone, and welcome to Fractal's Q3 2026 presentation. Today, we'll take you through our results, the progress that we've made, and our priorities ahead after a difficult first h…